Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14
188 (19): 5142 DOI: 10.1016/j.cell.2025.05.042 Cite This Page : ScienceDaily
ACS Mater Au
Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.
The NIH gives an intravenous infusion safety initiative that IV infusions outside of clinical settings may carry risks if done improperly
US$ 27.33
US$ 21.35
US$ 23.90
US$ 20.02
